ValiRx PLC - Agreement to License VAL401 to Ambrose Healthcare
VAL
Tue, 05 Dec 2023, 02:00pm GMT
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Industry: Health Care
Contact: +44 (0)2476 796496
Barling Way
https://www.valirx.com/
Dr Suzanne Dilly, CEO of Valirx discusses the agreement to License VAL401 to Ambrose Healthcare, a private UK specialist pharmaceutical company.
